Nobaxin (Azithromycin)

Azithromycin, the active ingredient in Nobaxin, is a macrolide antibiotic presented as an oral tablet for systemic use. It is commonly employed to treat various bacterial infections, including those affecting the respiratory tract, sinuses, throat, middle ear, skin and genital system, in both adult and pediatric patients.

GNH USA supplies Nobaxin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company emphasizes quality assurance, regulatory compliance and reliable delivery through established distribution networks across multiple regions.

Azithromycin is a macrolide antibiotic used to treat bacterial infections in the respiratory, ENT, skin and genitourinary systems.

Community‑acquired pneumonia: reduces bacterial load and improves clinical symptoms in adults and children. Acute bacterial sinusitis: alleviates sinus inflammation and clears pathogenic bacteria. Acute bacterial pharyngitis/tonsillitis: shortens disease duration and relieves throat pain. Acute otitis media: eradicates middle‑ear pathogens and restores hearing function. Skin and soft‑tissue infections: eliminates causative organisms and promotes wound healing. Uncomplicated genital chlamydia infection: clears Chlamydia trachomatis and prevents transmission.

Azithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild to moderate stomach upset experienced after oral intake. - Diarrhea: loose stools that may be watery or contain mucus. - Abdominal pain: cramping or discomfort in the lower abdomen. - Headache: transient mild to moderate head pain. - Altered taste: temporary metallic or bitter sensation.

Serious or Rare Side Effects: - QT prolongation: potential cardiac arrhythmias, especially in patients with pre‑existing heart conditions. - Severe allergic reactions: including anaphylaxis, angioedema and skin rash. - Hepatotoxicity: elevated liver enzymes or, rarely, clinically significant liver injury. - Clostridioides difficile colitis: severe diarrhea due to overgrowth of C. difficile. - Stevens‑Johnson syndrome: rare but life‑threatening mucocutaneous reaction.

Before prescribing Nobaxin, clinicians should consider several precautionary measures to ensure patient safety.

Cardiac assessment: evaluate risk of QT prolongation, especially in patients with known arrhythmias or electrolyte disturbances. Liver function: monitor hepatic enzymes in patients with pre‑existing liver disease. Drug interactions: review concomitant medications that may affect azithromycin metabolism or cardiac rhythm. Pregnancy and lactation: weigh potential benefits against unknown risks; use only if clearly indicated. Allergy history: avoid in patients with known hypersensitivity to macrolides. Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Azithromycin interacts with several medicines; some combinations should be avoided while others require close monitoring.

Major Interactions (Avoid): - QT‑prolonging agents: avoid co‑administration with drugs such as quinidine, sotalol or certain anti‑arrhythmics. - Antacids containing aluminum or magnesium: may reduce azithromycin absorption; separate dosing by at least 2 hours. - Warfarin: azithromycin can increase INR; monitor coagulation parameters closely.

Moderate Interactions (Monitor Closely): - Statins (e.g., simvastatin, atorvastatin): increased risk of myopathy; consider dose adjustment. - Oral contraceptives: azithromycin may reduce efficacy; advise additional contraceptive measures. - HIV protease inhibitors (e.g., ritonavir): may increase azithromycin levels; monitor for toxicity.